The US Department of Health and Human Services recently made a bold move. They ended a contract with Moderna. The contract was for developing an mRNA vaccine for bird flu. The reason given was that mRNA technology is not well-tested. This decision sparked a response from Pfizer's CEO, Dr. Albert Bourla. He strongly disagreed with the claim that mRNA vaccines are unde...

The nation's vaccine landscape is undergoing significant changes. At the heart of these shifts is Robert F. Kennedy Jr. He has promised to work within the existing system. However, his team is hinting at major overhauls. The Food and Drug Administration (FDA) is preparing to roll out a new approach to vaccine testing and approval. This new framework is being led...